A Trial of Antroquinonol in Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2019-07-09
Target enrollment:
Participant gender:
Summary
This is a multi-centers, phase IIa, double blind, randomized, placebo-controlled trial of
Antroquinonol in patients with atopic dermatitis.Duration of treatment is 12 week in total.
Study visits will occur every 4 weeks. AEs/SAEs, changes to concomitant medications will be
noted, vital signs will be taken, and efficacy evaluations will be performed as well. The
last estimation of variable scores will occur for all subjects.